One of the emerging immune escape mechanisms in cancer also involves an increased secretion of TSAs, TSA-MHC complexes, oncogenic proteins and RNAs in extracellular vesicles (EVs) [40,41,42]. This evidence concerns the gene HLA-C and cancer.